Maiuthed, A.; Ninsontia, C.; Erlenbach-Wuensch, K.; Ndreshkjana, B.; Muenzner, J.K.; Caliskan, A.; Ahmed P., H.; Chaotham, C.; Hartmann, A.; Vial Roehe, A.;
et al. Cytoplasmic p21 Mediates 5-Fluorouracil Resistance by Inhibiting Pro-Apoptotic Chk2. Cancers 2018, 10, 373.
https://doi.org/10.3390/cancers10100373
AMA Style
Maiuthed A, Ninsontia C, Erlenbach-Wuensch K, Ndreshkjana B, Muenzner JK, Caliskan A, Ahmed P. H, Chaotham C, Hartmann A, Vial Roehe A,
et al. Cytoplasmic p21 Mediates 5-Fluorouracil Resistance by Inhibiting Pro-Apoptotic Chk2. Cancers. 2018; 10(10):373.
https://doi.org/10.3390/cancers10100373
Chicago/Turabian Style
Maiuthed, Arnatchai, Chuanpit Ninsontia, Katharina Erlenbach-Wuensch, Benardina Ndreshkjana, Julienne K. Muenzner, Aylin Caliskan, Husayn Ahmed P., Chatchai Chaotham, Arndt Hartmann, Adriana Vial Roehe,
and et al. 2018. "Cytoplasmic p21 Mediates 5-Fluorouracil Resistance by Inhibiting Pro-Apoptotic Chk2" Cancers 10, no. 10: 373.
https://doi.org/10.3390/cancers10100373
APA Style
Maiuthed, A., Ninsontia, C., Erlenbach-Wuensch, K., Ndreshkjana, B., Muenzner, J. K., Caliskan, A., Ahmed P., H., Chaotham, C., Hartmann, A., Vial Roehe, A., Mahadevan, V., Chanvorachote, P., & Schneider-Stock, R.
(2018). Cytoplasmic p21 Mediates 5-Fluorouracil Resistance by Inhibiting Pro-Apoptotic Chk2. Cancers, 10(10), 373.
https://doi.org/10.3390/cancers10100373